U.S. stocks are slipping Wednesday and pulling back from their recent record highs as virus cases surge and coronavirus vaccines move closer to distribution. A vaccine from Pfizer and German partner BioNTech, which is already in use in the UK, is on track for a positive review and potential approval in the United States within the next week. The Food and Drug Administration will also consider a vaccine developed by Moderna later this month. The prospect for a vaccine is giving Wall Street hope that the economy is nearing a more direct path to a full recovery. But there could be more economic damage in store over the next few months and investors are still closely watching Washington for any developments on another shot of stimulus for people, businesses, and state governments. Congress is still divided over the size and scope of any new package and the Trump administration has …
US Stocks Slip on Wall Street; S&P 500 Backs Off Record
